BVI unveils new Virtuoso surgical platform
Ophthalmic device company BVI announced its first dual-function phaco-vitrectomy system, Virtuoso, to the European market.1 Virtuoso is a surgical platform designed for both cataract and vitreoretinal procedures.
BVI plans to introduce the new system at this year’s Congress of the European Society of Retina Specialists (EURETINA) being held September 4-7, 2025, in Paris.
Abstracts on Virtuoso will be present in the EURETINA Scientific Program, highlighting data about post-occlusion break surge, energy delivery consistency, vitrectomy probe stiffness, and aspiration efficiency. To further research on the platform, Prof. Siegfried G. Priglinger is leading a prospective, single-center, clinical investigation at LMU Klinikum, Munich, Germany, with the aim of confirming the safety and efficacy of Virtuoso.
“Virtuoso represents a significant leap in surgical technology, bringing efficiency and control to both anterior and posterior segment procedures,” Shervin Korangy, president and CEO of BVI, said in a press release.
“With Virtuoso, we are expanding our presence in the equipment segment of ophthalmology and look forward to watching millions of patients benefit from this technology. The excitement from the ophthalmic community for this much-anticipated introduction is palpable.”
Combining advanced technologies across fluidics control, vitreoretinal applications, ultrasound delivery, and usability, Vitreoso offers a high-performance platform with control and accuracy. This new device also offers a thoughtful footprint to maximize space in the operating room.
“Virtuoso has a very novel fluidics concept, maintaining target IOP throughout all procedure steps, from phaco to I/A, uniquely fusing the control of a flow pump with the efficacy of a pressure pump,” Dr Tommaso Rossi (Italy) said in a press release.
According to BVI, Virtuoso is “addressing the needs of a growing number of ambulatory surgical centers and hospitals seeking flexible, cost-effective platforms.”1 Built into one platform, the device is designed to provide versatility in multi-specialty centers, offering market-leading applications across cataract, vitrectomy, and combined procedures.
Vitreoretinal surgeon Dr David Steel (UK) noted the capabilities of the platform, saying, “The new Virtuoso platform shows very promising capabilities for vitreoretinal surgery: an enhanced aspiration performance matched with infusion under a variety of challenging scenarios, paired with high-speed and dual-action cutting performance, even under load with bent shaft.”
Commercial availability for Virtuoso will begin in select European markets, with a global rollout planned according to appropriate market approvals.
Reference:
BVI Medical, Inc. BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures. GlobeNewswire News Room. Published September 3, 2025. Accessed September 3, 2025. https://www.globenewswire.com/news-release/2025/09/03/3143764/0/en/BVI-Unveils-Virtuoso-A-Novel-Dual-Function-Surgical-Platform-for-Cataract-and-Vitreoretinal-Procedures.html?utm_source=chatgpt.com
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
